Table 2 Effects of amisulpride vs placebo and aripiprazole vs placebo on SART outcomes.
Amisulpride | ||||||||
|---|---|---|---|---|---|---|---|---|
Outcome variable | Amisulpride estimated marginal mean (SEM) | Placebo estimated marginal mean (SEM) | Fixed effect of amisulpride (beta) | SE of beta value | p-value (amisulpride vs placebo) | Model R2 | p-value (effect of order) | |
Balanced Integration Score | 1.0 (0.3) | 1.1(0.4) | −0.16 | 0.26 | 0.55 | 0.69 | 0.37 | |
Reaction time | 315.9 (10.1) | 313.4 (8.5) | 2.51 | 6.84 | 0.72 | 0.90 | 0.76 | |
Errors commission | 6.0 (1.1) | 6.3 (1.2) | −0.043 | 0.12 | 0.72 | 0.56 | 0.79 | |
Errors omission | 1.1 (1.35) | 0.6 (1.4) | 0.54 | 0.34 | 0.12 | 0.52 | 0.40 | |
Total errors | 6.9 (1.1) | 7.0 (1.2) | −0.0073 | 0.11 | 0.94 | 0.67 | 0.89 | |
Aripiprazole | ||||||||
Outcome variable | Aripiprazole estimated marginal mean (SEM) | Placebo estimated marginal mean (SEM) | Fixed effect of aripiprazole (beta) | SE of beta value | p-value (aripiprazole vs placebo) | Model R2 | p-value (effect of order) | |
Balanced Integration Score | 1.5 (0.3) | 1.2 (0.4) | 0.22 | 0.31 | 0.49 | 0.88 | 0.16 | |
Reaction time | 325.4 (13.6) | 320.3 (8.5) | 5.12 | 10.0 | 0.61 | 0.88 | 0.72 | |
Errors commission | 4.5 (1.2) | 4.5 (1.2) | 0.02 | 0.15 | 0.90 | 0.65 | 0.69 | |
Errors omission | 0.4 (1.5) | 0.5 (1.6) | 0.16 | 0.33 | 0.64 | 0.64 | 0.07 | |
Total errors | 5.1 (1.2) | 5.2 (1.2) | −0.019 | 0.15 | 0.90 | 0.83 | 0.26 | |
